share_log

雲頂新耀-B：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 5 06:54
Summary by Moomoo AI
雲頂新耀有限公司（云顶新耀-B）於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股份變動情況。該報告顯示，公司的法定/註冊股本維持不變，為500,000,000股普通股，每股面值0.0001美元，總股本為50,000美元。已發行股份在本月有所增加，從上月的323,714,720股增至323,983,170股，增加了268,450股。該增加主要來自於股份期權的行使，包括首次公開發售前管理層及僱員購股權計劃，以及首次公開發售後購股權計劃。本月內因行使期權所得資金總額為377,403.76港元。此外，報告還提到，根據首次公開發售前僱員購股權計劃授出的受限制股份單位於本月內歸屬，並有部分受限制股份單位及獎勵股份被註銷。公司確認所有證券發行均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
雲頂新耀有限公司（云顶新耀-B）於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股份變動情況。該報告顯示，公司的法定/註冊股本維持不變，為500,000,000股普通股，每股面值0.0001美元，總股本為50,000美元。已發行股份在本月有所增加，從上月的323,714,720股增至323,983,170股，增加了268,450股。該增加主要來自於股份期權的行使，包括首次公開發售前管理層及僱員購股權計劃，以及首次公開發售後購股權計劃。本月內因行使期權所得資金總額為377,403.76港元。此外，報告還提到，根據首次公開發售前僱員購股權計劃授出的受限制股份單位於本月內歸屬，並有部分受限制股份單位及獎勵股份被註銷。公司確認所有證券發行均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Genting Xinyu Limited (Genting Xinyao -B) submitted its latest Securities Change Month Report to Hong Kong Trading and Settlement Limited on March 5, 2024, reporting stock changes as of February 29, 2024. The report showed that the company's regulated/registered share capital remained unchanged at 500,000,000 shares of ordinary shares with a face value of $0.0001 per share and a total share capital of $50,000. Issued shares increased this month, increasing to 323,983,170 shares from 323,714,720 shares in the previous month, an increase of 268,450 shares. The increase resulted primarily from the exercise of stock options, including the management pre-IPO and employee stock option schemes, and the IPO post-IPO share option scheme. The total amount of capital gained from the exercise of options during the month was...Show More
Genting Xinyu Limited (Genting Xinyao -B) submitted its latest Securities Change Month Report to Hong Kong Trading and Settlement Limited on March 5, 2024, reporting stock changes as of February 29, 2024. The report showed that the company's regulated/registered share capital remained unchanged at 500,000,000 shares of ordinary shares with a face value of $0.0001 per share and a total share capital of $50,000. Issued shares increased this month, increasing to 323,983,170 shares from 323,714,720 shares in the previous month, an increase of 268,450 shares. The increase resulted primarily from the exercise of stock options, including the management pre-IPO and employee stock option schemes, and the IPO post-IPO share option scheme. The total amount of capital gained from the exercise of options during the month was HK$377,403.76. In addition, the report notes that restricted shares granted under the Employee Stock Option Scheme prior to initial public offering were divested during the month and some restricted units and bonus shares were written off. The Company confirms that all securities issues have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more